Denisovan Zinc Variant: Cell Effects, Not Proven Brain Harm

A genetic variant linked to Denisovan ancestry has a measurable effect on zinc handling in laboratory-grown cells. The evidence still does not show that ancient interbreeding produced a harmful change in the human brain or that the variant causes psychiatric illness.

Later research has reinforced the broader finding that inherited Denisovan DNA can remain biologically active in living populations. It has also made the crucial limitation clearer: the consequences depend on the particular variant, population and cellular context, so archaic origin alone cannot establish a health effect.

What researchers tested

The variant, rs1047626, occurs in SLC30A9, the gene encoding the zinc transporter ZnT9. It changes the protein at amino-acid position 50 from methionine to valine, producing the form commonly described as 50Val.

The 2023 primary research article describes experiments in which researchers expressed the 50Met and 50Val forms in HEK293 cells and measured zinc inside cellular compartments. The 50Val form altered zinc responses in the endoplasmic reticulum and mitochondria and produced a higher mitochondrial metabolic signal under the tested conditions.

These were controlled molecular experiments, not examinations of people’s brains. The researchers did not use brain imaging, analyze living neural tissue, follow carriers for psychiatric outcomes or calculate a clinical risk for an individual who inherits the allele.

The experimental design also matters. The cells were engineered to overexpress the two forms of ZnT9, allowing researchers to detect functional differences between them. That result establishes a cellular phenotype under laboratory conditions, but it does not by itself reveal the magnitude or even the direction of an effect in an intact human organ.

Why the variant is linked to Denisovans

The derived 50Val allele is present in the sequenced Denisovan genome. Modern haplotypes carrying it also share a long surrounding stretch of derived alleles with that genome, and the original analysis found that ordinary inheritance from a distant common ancestor was an unlikely explanation for the length of the shared segment.

That makes archaic introgression—the transfer of DNA through interbreeding—a strong explanation. It does not mean every carrier inherited the sequence through the same simple population history, however, or that the allele is uniformly distributed among everyone whose ancestry lies outside Africa.

A review published in November 2024 identifies evidence for at least three introgression events involving distinct Denisovan populations. Different Denisovan-related groups therefore contributed different genetic segments to different modern populations, complicating any claim about a single universal “Denisovan legacy.”

This distinction is especially important for SLC30A9. The original analysis found the derived allele at substantial frequencies in several non-African populations, but Denisovan-like ancestry is not one homogeneous category, and the presence of an archaic-looking haplotype does not tell researchers what it does in every tissue.

The cold-adaptation idea remains a hypothesis

The 50Val allele’s wide distribution and evidence of selection led the researchers to propose that it may have been advantageous. Because ZnT9 affects mitochondrial zinc balance and metabolism, they suggested that the cellular changes could have helped ancestral populations respond to cold environments.

That interpretation is biologically plausible, but the experiment did not reproduce an ancient climate or measure whether carriers survived cold more successfully. Selection signals can identify a genetic region that probably affected reproductive success; they do not automatically identify the environmental pressure responsible.

The absence of a significant difference in systemic zinc levels among the genotypes examined in the original work adds another boundary. The finding concerns intracellular zinc regulation and metabolism, not evidence that carriers generally have too much or too little zinc in their bodies.

Where the mental-health claim comes from

The psychiatric argument was built from earlier genetic associations involving the SLC30A9 region, combined with the new cellular findings and the known importance of zinc regulation in biology. The authors proposed that a historically advantageous allele might also contribute to susceptibility to neuropsychiatric traits in present-day environments.

Susceptibility is not the same as causation or diagnosis. An association can reflect linkage with another variant, population structure or effects too small and context-dependent to predict an individual outcome. Psychiatric conditions are also polygenic and influenced by developmental, social and environmental factors.

The 2023 work did not demonstrate that 50Val initiates depression, schizophrenia, bipolar disorder or another psychiatric condition. It did not provide an absolute risk for carriers, show that the variant is necessary or sufficient for illness, or establish that testing it would help with diagnosis or treatment.

Calling the result a “change in our brains” therefore collapses several unproven steps into one claim. A zinc transporter behaved differently in engineered cells; the study did not establish a neurological lesion, an altered brain structure or a psychiatric outcome in living people.

What the newer functional evidence adds

A PLOS Genetics study published in March 2026 tested 25,869 candidate Neanderthal- and Denisovan-introgressed variants found in people of Papuan genetic ancestry. Its reporter assays identified regulatory activity for a subset of sequences in immune-cell contexts, including differences between some archaic and modern alleles.

That work did not test SLC30A9, brain tissue or psychiatric outcomes. Its relevance is methodological: it demonstrates how candidate archaic variants can be screened experimentally while showing that functional effects are neither automatic nor interchangeable across genes and cell types.

The newer results also resist a simple “archaic DNA is harmful” narrative. Some inherited variants can affect gene regulation, some show no detectable difference in a given assay, and an effect measured in immune cells cannot be transferred without evidence to neurons or other tissues.

The boundary of the evidence

Modern humans did interbreed with Denisovan populations, and inherited archaic DNA still influences cellular biology. For rs1047626, the strongest direct finding is narrow but meaningful: the Denisovan-linked 50Val form of ZnT9 changes intracellular zinc handling and mitochondrial behavior in experimental cells.

The proposed cold advantage remains an evolutionary interpretation, while the psychiatric connection remains an association awaiting relevant functional and clinical evidence. Until research connects the variant to measured effects in human neural tissue and to health outcomes in well-designed population studies, a damaging alteration of “our brains” is not a conclusion the data support.

A Denisovan-Linked Zinc Variant Alters Cells—Not Proven to Change Brains